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Abstract 
To compare regional thallium-201 SPECT redistribution patterns with rubidium-82 PET, we studied 81 patients 
with both imaging modalities. Sixty patients had significant coronary artery disease. All patients underwent PET 
imaging after dipyridamole infusion, while SPECT imaging was performed after exercise stress (38 patients) and 
dipyridamole (43 patients). Sixty-eight percent of patients with prior infarct had fixed defects on SPECT, compared 
to 39% with PET. Sixty-one percent of patients with prior infarct had PET perfusion defects which exhibited 
'reflow' or normal rubidium-82 tracer uptake (p < 0.05 vs. SPECT). Similar results were seen in patients without 
prior infarct (26% fixed defects on SPECT vs. 12% for PET, p < 0.05). Regional analysis showed that 57% of 
fixed SPECT defects corresponded to PET defects with reflow or normal rubidium-82 uptake, while 78% of 'fixed' 
PET defects corresponded to fixed SPECT defects. PET reflow and normal rubidium-82 uptake in sites of fixed 
thallium-201 SPECT perfusion defects suggest that imaging modalities employing separate tracer injections at 
rest and after stress, such as rubidium-82 PET, may be more specific in the assessment of myocardial viability, 
especially in patients with prior myocardial infarction. 
Introduction 
Stress and delayed myocardial perfusion imaging with 
thallium-201 has been established as an important clin- 
ical tool for the detection and assessment of coro- 
nary artery disease [ 1 ]. Thallium-201 perfusion defects 
which demonstrate redistribution (or reversibility) on 
3 to 4 hour delayed images have been associated with 
hypoperfused viable myocardium [2]. Studies investi- 
gating late redistribution of thallium-201 single pho- 
ton emission computed tomography (SPECT) defects, 
along with correlation with other imaging modalities 
such as positron emission tomography (PET), suggest 
that approximately 50% of viable myocardial segments 
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are assessed as non-reversible or 'fixed' at four hours 
[3, 4]. Study protocols involving 24-hour delayed 
imaging and reinjection of thallium-201 after initial 
stress imaging are being used to improve the diagnostic 
performance of thallium-201 in assessing myocardial 
viability [5, 6]. However, due to logistical consider- 
ation, many institutions still employ standard stress- 
redistribution imaging protocols with thallium-201. 
Positron emission tomography imaging with the 
potassium analog rubidium-82 has been shown to rep- 
resent a diagnostically accurate alternative to thallium- 
201 SPECT for the detection of coronary artery dis- 
ease [7-9]. Unlike perfusion imaging with thallium- 
201 SPECT, rubidium-82 requires two separate injec- 
tions of tracer at baseline and after stress. The favor- 
able imaging characteristics of PET in addition to the 
attractive physical properties of rubidium-82 (half-life 
of 76 sec) offer the ability to perform baseline and stress 
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imaging after intravenous dipyridamole or adenosine 
administration within a one hour time period [10]. 
Furthermore, rubidium-82 uptake in myocardium at 
rest occurs by a different mechanism than thallium- 
201 redistribution. Very little data has been report- 
ed comparing the pattern of rubidium-82 myocar- 
dial perfusion at rest and after pharmacologic stress 
with thallium-201 redistribution imaging. According- 
ly, the purpose of the following study was to com- 
pare thallium-201 SPECT redistribution patterns with 
rubidium-82 PET imaging at rest and following intra- 




The study group consisted of patients that formed the 
basis of a previous report [9] referred to our institu- 
tion for diagnostic coronary angiography. All patients 
with previous surgical revascularization or percuta- 
neous transluminal coronary angioplasty (PTCA) were 
excluded. Referral diagnosis included chest pain, his- 
tory of myocardial infarction, pre-surgical evaluation, 
and abnormal stress tests. In addition, six patients with 
a low likelihood of coronary artery disease based on 
age, sex, and risk factors who did not undergo coronary 
angiography were selected. All studies were performed 
within a three-week time period. Patients with chang- 
ing clinical status between studies were excluded. All 
patients were asked to sign an informed consent form 
approved by the committee for clinical research at the 
University of Michigan before entering the study. 
Positron emission tomography 
All patients were studied after overnight fast using a 
15 slice whole body PET scanner (931 CTI/Siemens, 
Knoxville, TN). A transmission scan using a 
retractable Germanium-68 ring source was performed 
for 15-20 minutes (100-200 million counts) for patient 
positioning and attenuation correction. The transmis- 
sion scan was followed by a baseline PET study 
with 60 mCi of rubidium-82 using the commercially 
available SR-82/Rb-82 generator (Squibb Diagnostics, 
Princeton, NJ) and infusion system (CTI, Knoxville, 
TN). Rubidium-82 was infused with a pump setting 
of 50 ml/min and a specific activity of 1 to 2 mCi/ml. 
Sixty seconds following the end of rubidium-82 infu- 
sion, data were acquired for seven minutes. Fifteen 
minutes following the resting study, an intravenous 
infusion of dipyridamole (0.56 mg/kg) was started for 
four minutes. Four minutes after the end of the dipyri- 
damole infusion, the patients were asked to perform 
handgrip exercise at 30% of maximal strength [11]. 
One minute after the initiation of handgrip exercise, a 
second 60 mCi dose of rubidium-82 was infused using 
the same protocol as above. Handgrip stress lasted 
for a total of three minutes. The time required for rest 
and stress rubidium-82 PET imaging averaged approx- 
imately one hour. 
PET image processing 
The attenuation corrected projection data were used 
to reconstruct transverse images with a Hanning filter 
(cutoff frequency 0.35 cycles/pixel). Using a computer 
workstation (SUN Systems, Mountain View, CA) and 
dedicated software (Volumn Tool, CTI) the transverse 
images were realigned perpendicular to the long axis 
of the left ventricle, yielding cross-sectional short-axis 
and longitudinal images. 
PET data analysis 
All images were evaluated by two observers blinded to 
clinical, angiographic, and thallium-201 SPECT data. 
A four-point visual scoring system was used [9]. In cas- 
es of disagreement, a third observer graded the images. 
The cross-sectional images were displayed in the same 
format as the thallium-201 SPECT images. A score of 
one represented normal rubidium-82 uptake, with two 
being equivocal, three being mildly abnormal, and four 
markedly abnormal. Visual assessment was performed 
in four regions of three ventricular slices (apical lev- 
el, mid level, and basal level). Each of these slices 
was divided into anterior, lateral, inferior, and sep- 
tal regions. A final perfusion score for each region was 
derived from the average of the three ventricular slices. 
A tracer uptake defect was defined as a score of three 
or greater in at least one of the four regions. Reflow 
on a rubidium-82 PET study was present if the aver- 
aged perfusion score in the anterior, lateral, inferior, or 
septal regional differed by more than one between the 
stress (post dipyridamole) and rest studies. 
Thallium-201 SPECT 
Thallium-201 SPECT was performed either in com- 
bination with exercise testing or intravenous dipyri- 
damole infusion. All patients were fasted for at least 
eight hours prior to the study. In those patients undergo- 
ing exercise stress testing, the standard Bruce protocol 
was utilized. At peak exercise, 3-4 mCi thallium-201 
was injected intravenously and exercise continued for 
one minute. Immediately following exercise, patients 
were placed in the supine position, and a five minute 
planar image in the anterior position was acquired. 
SPECT acquisition began 10 to 15 minutes after the 
end of exercise and was completed within 45 minutes 
after tracer administration. 
Patients undergoing pharmacologic stress testing 
received a four minute intravenous infusion of dipyri- 
damole (0.56 mg/kg). Four minutes after the end of 
the infusion, the patient was asked to perform hand- 
grip exercise for three minutes. Imaging was started 
ten minutes after the injection of thallium-201 using 
the same protocol as following exercise testing. 
SPECT data acquisition 
Image acquisition was performed using a General 
Electric 400 AC gamma camera system interlinked 
to a MicroDELTA Workstation (Siemens). Data were 
acquired over a 180 degree angle starting from the 
45 degree right anterior oblique projection. Data col- 
lection consisted of 64 steps of 15 seconds each. All 
patients underwent redistribution imaging 4 to 6 hours 
after the initial thallium-201 injections. 
SPECT image processing 
Image processing consisted of filtered back projection 
of data in a 64 x 64 matrix with reconstruction of the 
transverse images using the Butterworth filter (cutoff 
frequency 0.35 cycles/pixel) and commercially avail- 
able software (MicroDELTA Workstation, Siemens). 
The tomographic images were realigned perpendicu- 
lar to the long axis of the left ventricle. All images 
were displayed in grey scale using a large screen dis- 
play system and customized software. This method 
allowed direct comparison of stress and redistribution 
images in oblique, longitudinal, and sagittal views. 
SPECT data analysis 
As with rubidium-82 PET images, all studies were 
evaluated by two observers blinded to clinical, angio- 
graphic, and PET data using a four-point visual scoring 
system, In cases of disagreement, a third observer was 
consulted. The left ventricle was divided into 12 seg- 
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ments (anterior, lateral, inferior, and septal segments 
at the apical, mid, and basal levels) and the stress and 
redistribution images were evaluated using the same 
scoring system as with the PET studies. Reversibility 
on thallium-201 SPECT was defined as an averaged 
difference of one scoring point between stress and 
redistribution images in one or more left ventricular 
region (anterior, lateral, inferior, or septal). 
Coronat?/ angiography 
Cineangiograms of the coronary arteries were obtained 
in multiple projections using a C-core Angiographic 
System (Siemens). Quantitative assessment of coro- 
nary artery stenosis was carried out as described pre- 
viously [9]. A coronary artery diameter stenosis of 
greater than 50% was considered significant. 
Determination of myocardial infarction 
The presence of infarcted segmental myocardial 
regions was determined by 1) history of previous 
myocardial infarction; 2) presence of characteristic 
ECG changes (Q waves); 3) documentation of ele- 
vated serum creatinine kinase levels (> 225 IU/L, with 
3 % MB fraction levels); 4) evidence of regional resting 
wall motion abnormalities on ventriculography. 
Statistical analysis 
All data were expressed as the mean 4- 1 standard devi- 
ation. Paired t-tests were used to compare differences 




Eighty-one patients (52 male, 29 female) with a mean 
age of 57 + 12 yrs comprised the study group. Thirty- 
eight patients had clinical, electrocardiographic, ven- 
triculographic, or enzymatic evidence of prior myocar- 
dial infarction. Seventy-five patients underwent coro- 
nary angiography. Sixty of 81 patients had significant 
coronary artery disease (_> 50% diameter stenosis) 
involving at least one maior coronary artery, while 
21 patients were considered free from coronary artery 
disease. 
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Fig. l. Reconstructed short-axis rubidium-82 PET (A) and thal- 
lium-201 SPECT (B) images in a patient with significant coronary 








A. Prior History of Infarct (n = 38) 
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Thallium-201 SPECT Rubidium-82 PET 
Fig. 2. Imaging results per patient. There is a significant difference 
(p < 0.05) in the imaging patterns between thallium-201 SPECT 
and rubidium-82 PET in patients with (A) and without (B) prior 
myocardial infarction. PD = perfusion defects. 
Stress testing 
All patients underwent intravenous dipyridamole infu- 
sion in combination with rubidium-82 PET imaging. 
Thirty-eight patients underwent exercise thallium-201 
SPECT. The rate pressure product for exercise aver- 
aged 26,314 :t: 3,077. Forty-eight patients underwent 
dipyridamole thallium-201 SPECT. There were no 
serious complications during or after dipyridamole 
infusion in any patient. 
Overall imaging results per patient 
Figure 1 shows a rubidium-82 PET (A) and thallium- 
201 SPECT (B) study in the short-axis view. Both PET 
and SPECT stress images reveal an inferior wall per- 
fusion defect consistent with a high degree of coronary 
artery stenosis involving the right coronary artery. This 
example represents a patient with a previous inferior 
wall myocardial infarction. The thallium-201 SPECT 
images demonstrate a fixed inferior wall defect. The 
rubidium-82 PET images after dipyridamole stress 
show a larger inferior defect compared to the rest 
images, suggesting the coexistence of necrotic and 
viable but jeopardized myocardium. 
Figure 2 shows the imaging results per patient 
with prior history of myocardial infarction. Sixty- 
eight percent (26/38) of patients that had primarily 
fixed perfusion defects on thallium-201 SPECT in 
comparison to 39% (15/38) of patients with 'fixed' 
(no reflow) rubidium-82 PET tracer uptake abnormal- 
ities (p < 0.05). Likewise, 24% (9/38) of patients 
had primarily reversible thallium-201 SPECT perfu- 
sion defects as opposed to 53% (20/38) of patients 
with rubidium-82 PET reflow defects (p < 0.05). Eight 
percent of patients (3/38) had normal SPECT and PET 
studies. In patients without prior myocardial infarction, 
26% (11/43) of patients had fixed perfusion defects 
on thallium-201 SPECT compared to 12% (5/43) on 
PET studies (p < 0.05). A similar number of patients 
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F/g. 3. Comparison of the frequency of regional perfusion defects 
and normal myocardial tracer uptake in 183 regions lacking signifi- 
cant coronary artery disease (< 50% diameter stenosis). 
rubidium-82 PET perfusion defects with reflow (16/43, 
37%). Thirty-five percent of patients (15/43)had nor- 
mal thallium-201 SPECT studies compared to 51% 
(22/43) for rubidium-82 PET (p < 0.05). 
Overall imaging results per myocardial region 
Three hundred twenty-four myocardial regions were 
evaluated. For thallium-201 SPECT studies, 81 regions 
(25%) had fixed perfusion defects without redistribu- 
tion while 54 regions (17%) had reversible defects. 
One hundred eighty-nine regions (58%) were normal. 
For rubidium-92 PET studies, 45 regions (14%) had 
similar perfusion defects on both baseline and post- 
dipyridamole images, while 61 regions (19%) exhib- 
ited a smaller rubidium-82 defect at baseline as com- 
pared to post-dipyridamole studies (reflow). Two hun- 
dred eighteen regions (67%) showed normal rubidium- 
82 uptake. Agreement between thallium-201 SPECT 
and rubidium-82 PET was 79%. 
Figure 3 shows the imaging patterns in myocar- 
diai regions without significant coronary artery disease 
(n = 183). Thallium-201 SPECT defects were fixed in 
14% of regions (25/183), reversible 9% (16/183), and 
normal in 77% (142/183). This is in contrast to 94% 
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Fig. 4. Frequency of myocardial perfusion defects and normal tracer 
uptake in regions with >_ 50% diameter stenosis (n = 141 regions). 
uptake of rubidium-82, 4% (7/183) showing fixed per- 
fusion defects without reflow, and 2% (4/183) showing 
defects with rubidium-82 PET reflow. 
Figure 4 shows all myocardial regions with signifi- 
cant coronary artery disease (n = 141). Fixed thallium- 
201 SPECT defects accounted for 40% (56/141) of 
regions, while 27% (38/141) of regions had reversible 
defects, and 33% (47/141) were normal. PET images 
revealed 27% (38/141) of regions fixed without reflow, 
40% (57/141) demonstrating reflow, and 33% (46/141) 
normal. 
In the 54 myocardial regions that had sustained 
infarction (Fig. 5), 67% (36/54) showed fixed defects 
on thallium-201 SPECT, while 22% (12/54)of regions 
had reversible defects, and 11% (6/54) were normal. 
Rubidium-82 uptake was fixed in 43% (23/54) of 
regions on PET studies, but showed reflow in 48% 
(26/54). Normal rubidium-82 uptake was present in 
9% (5/54) of regions. 
Relationship between fixed thallium-201 SPECT 
defects and regional rubidium-82 PET reflow 
Table 1 shows all fixed thallium-201 SPECT and 
rubidium-82 PET perfusion abnormalities, and the 
imaging appearance of the corresponding myocardial 
regions as assessed by the other modality. Forty- 
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Fig. 5. Results of thallium-201 SPECT and rubidium-82 PET in 54 
infarcted myocardial regions. Normal thallium-201 and rubidium-82 
uptake was noted in only 9% of regions. 
Table 1. 
Fixed Reversible Normal 
PD PD stress 
/rest 
Rb-82 PET 35/45 7/45 3/45 
(78%) (15%) (7%) 
T1-201 SPECT 35/81 20/81 26/81 
(43%) (25%) (32%) 
Appearance of corresponding myocardial 
segments to 'fixed' rubidium-82 PET 
(n = 45 segments) and thallium-201 SPECT 
(n = 81 segments) perfusion defects from 
both infarcted and non-infarcted myocardial 
segments. Fixed PD = corresponding fixed 
perfusion defects, reversible PD =corresponding 
reversible perfusion defects, and normal 
stress/rest = corresponding myocardial segments 
with normal tracer uptake. 
three percent (35/81) of fixed thallium-201 SPECT 
defects had corresponding rubidium-82 PET tracer 
uptake abnormalities on PET studies which did not 
exhibit reflow, while 25% (20/81) of corresponding 
regions had rubidium-82 perfusion abnormalities with 
Table 2. 
Fixed Reversible Normal 
PD PD stress 
/rest 
Rb-82 PET 20/23 2/23 1/23 
(87%) (9%) (4r 
T1-201 SPECT 20/36 13/36 3/36 
(56%) (36%) (8%) 
Appearance of corresponding myocardial 
segments to 'fixed' rubidium-82 PET (n = 23) 
and thallium-201 SPECT (n = 36) perfusion defects 
from infarcted myocardial segments only. 
reflow. Thirty-two percent (26/81) of fixed thallium- 
201 SPECT perfusion defects corresponded to regions 
with normal rubidium-82 uptake. Conversely, 78% 
(35/45) of fixed rubidium-82 perfusion abnormali- 
ties had corresponding thallium-201 SPECT defects 
that appeared fixed, while only 15% (7/45) of fixed 
rubidium-82 PET defects corresponded to reversible 
thallium-201 SPECT defects. Only 7% (3/45) of corre- 
sponding myocardial regions were normal by thallium- 
201 SPECT. 
In a similar format, Table 2 compares fixed region- 
al SPECT and PET defects in the infarcted regions 
only. Fifty-six percent (20/36) of fixed thallium-201 
SPECT perfusion defects corresponded to rubidium- 
82 PET defects without reflow, while 36% (13/36) cor- 
responded to PET defect with reflow, and 8% (3/36) 
to regions with normal rubidium-82 uptake. Eighty- 
seven percent (20/23) of regions with fixed rubidium- 
82 uptake abnormalities on PET studies corresponded 
to fixed SPECT perfusion defects, while 9% (2/23) cor- 
responded to reversible SPECT defects, and 4% (1/23) 
to regions appearing normal by SPECT. 
Exercise versus dipyridamole thallium-201 SPECT 
Since 43 patients underwent thallium-201 SPECT after 
dipyridamole infusion and 28 after maximal exercise, 
the imaging patterns obtained after these two modes of 
stress were compared. Summarized in Table 3 are the 
numbers of fixed and reversible regional thallium-201 
SPECT perfusion defects along with normal regions. 
The incidence of fixed thallium-201 SPECT defects 
after dipyridamole infusion (29%) did not differ sig- 
Table 3. 
Fixed Reversible Normal 








23/172 29/172 120/172 
(13%) (17%) (70%) 
37/172 28/172 107/172 
(23%) (16%) (62%) 
22/152 26/152 82/152 
(14%) (21%) (65%) 
44/152 26/152 82/152 
(29%) (17%) (54%) 
Segmental rubidium-82 PET and thallium-201 SPECT 
imaging patterns after exercise (Bruce protocol) 
and dipyridamole stress. 
nificantly from the post-exercise studies (22%). A sim- 
ilar result is seen with reversible defects (17% post- 
dipyridamole infusion vs. 16% post-exercise stress) 
and normal segments (45% vs. 62%). 
Discussion 
In the present study, the imaging patterns of thallium- 
201 SPECT and rubidium-82 PET were compared 
in a population with proven or suspected coronary 
artery disease. Overall, there was a higher incidence of 
myocardial regions with fixed, or non-reversible per- 
fusion defects on thallium-201 SPECT studies (25%) 
than with rubidium-82 PET (14%). This result was 
also observed in the subpopulation of patients with 
proven coronary artery disease with and without pri- 
or myocardial infarction (Fig. 4). The agreement 
on fixed perfusion defects between both studies was 
only 43%, confirming previous studies using 24-hour 
delayed thallium-201 SPECT redistribution imaging 
or thallium-201 SPECT reinjection techniques [3, 6]. 
Resting rubidium-82 PET imaging may be more sen- 
sitive in detecting residual viable myocardium than 
thallium-201 SPECT, although a direct comparison 
of rubidium-82 PET rest imaging with functional 
outcome after revascularization or with F-18 fluo- 
rodeoxyglucose (FDG) imaging is required to prove 
this hypothesis. 
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A significantly larger number of patients with pri- 
or infarction have fixed thallium-201 SPECT defects 
in comparison to PET studies, as was also the case in 
the non-infarct patient population. Importantly, both 
in the overall study group and in patients with prior 
infarction, fixed thallium-201 SPECT regional per- 
fusion defects corresponded to a higher number of 
myocardial segments with rubidium-82 PET reflow or 
normal rubidium-82 uptake (Table 1 and 2). Thus, the 
high incidence of fixed thallium-201 SPECT perfusion 
defects with normal rubidium-82 uptake confirms the 
limited specificity of thallium-201 SPECT which may 
be related to the lack of photon attenuation correction 
[9]. The higher incidence of tracer uptake abnormali- 
ties with reflow seen with rubidium-82 in myocardial 
regions with fixed thallium-201 SPECT defects sug- 
gest that perfusion imaging employing separate tracer 
injections at baseline (rest) and stress may offer an 
advantage in the assessment of tissue viability. 
Redistribution of thallium-201 has been taken as a 
marker for transiently ischemic but viable myocardium 
resulting from coronary artery disease [12]. However, 
there are many instances where redistribution may be 
limited in detecting jeopardized tissue. Redistribution 
may not occur as readily in clinical situations where 
the myocardium is supplied by highly stenotic vessels 
with variable collaterals [13]. This was observed clini- 
cally in an early study by Ritchie et al. [12] who found 
that 44% of patients had thallium-201 perfusion defects 
that were more extensive on delayed images than post- 
stress images, suggesting an overestimation of scar. 
The explanations for this phenomenon are many, but 
probably involve the rapid reflux of tracer from infarct- 
ed cells interdigitated with viable myocardium [14], 
and the effect of hypoxia on net myocardial reten- 
tion on thallium-201 [15]. As was shown by Nelson et 
al. [16], thallium-201 blood levels can play a role in 
determining the incidence of reversible defects. In their 
study, the authors showed nearly a two-fold increase 
in the number of reversible defects in patients with 
significantly higher plasma thallium levels resulting 
from fasting. Finally, the relationship between dietary 
state and thallium-201 kinetics resulting in increased 
tracer clearance from myocardium has previously been 
addressed [17]. 
Delayed imaging up to 24 hours with thallium-201 
has been proposed as an alternative to the convention 
3 to 4 hour redistribution imaging with thallium [3]. 
Although this approach takes advantage of existing 
technology and avoids the cost of a PET system, logis- 
tical difficulties with patient scheduling and gamma 
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camera time may limit its widespread application. The 
clinical trial comparing 24-hour thallium-201 redistri- 
bution imaging with post-revascularization function- 
al recovery has indicated that 35% of segments with 
fixed defects demonstrated subsequent improvement 
in function. These data suggest improvement in the 
detection of viable myocardium using 24-hour imaging 
approaches, but the diagnostic accuracy is still limited 
[3]. 
More recently, reinjection of thallium in conjunc- 
tion with a same-day imaging protocol has been intro- 
duced to accelerate the scintigraphic detection of tissue 
viability. Several studies have idicated that reinjec- 
tion leads to increased thallium uptake in myocardial 
regions which were deemed fixed on 3 to 4 hour redis- 
tribution imaging [6, 18, 19]. Initial studies compar- 
ing the outcome of such regions following revascular- 
ization supports the notion that reinjection improves 
the identification of viable myocardium [20]. In the 
present study, standard stress-redistribution protocols 
with thallium-201 were employed without re-inj ection. 
However, it is still unclear at this time which thalli- 
um reinjection protocol is optimal for the assessment 
of tissue viability [21, 22]. The acquisition of 3 sep- 
arate studies may pose similar scheduling problems 
for a busy imaging department as would a 24-hour 
study. Until this issue is settled, many institutions 
will continue to utilize thallium-201 in standard stress- 
redistribution imaging protocols. 
Rubidium-82 is distributed in tissue in a matter 
similar to potassium and thallium. Rubidium-82 tissue 
retention has been shown to be decreased in myocardi- 
um during hypoxia and acidosis, but is unaltered by 
changes in the dietary state [23]. The extraction frac- 
tion of rubidium-82 by the myocardium is somewhat 
lower than that of thallium-201, but rubidium-82 has 
been successfully used as a blood flow marker in the 
detection of regional stress induced perfusion abnor- 
malities. The major advantage of rubidium-82 over 
thallium-201 lies in its short physical half-life and in 
its properties which allow its use in combination with 
positron emission tomography. The physical half-life 
of 76 seconds allows for separate rest and stress evalu- 
ation of left ventricular perfusion within 1 hour, which 
compares very favorably with the 4 to 5 hours required 
for thallium-201 SPECT or technetium-99 sestamibi 
imaging. Based on the thallium-201 data, it becomes 
apparent that resting injections of blood flow tracers 
are useful for the identification of tissue viability. Ani- 
mal studies have shown that myocardial blood flow is 
closely linked to myocardial oxygen consumption and, 
hence, to tissue viability [24, 25]. 
There also appears to be additional information 
on myocardial viability provided by the retention and 
clearance of rubidium-82 at rest. Thallium-201 redis- 
tribution following resting injection, which occurs in 
delayed images of thallium distribution in myocardi- 
urn, may be diagnostically superior to thallium stress 
reinjection images [26]. Similarly, Goldstein et al. have 
demonstrated in the animal model that rubidium-82 tis- 
sue kinetics in acute ischemia and necrotic myocardi- 
um are distinctly different [27, 28]. Work by Gould 
et al. indicates that the same principle can be applied 
to clinical data obtained with rubidium-82 PET [29]. 
Comparison of early tracer distribution after injection 
with delayed tracer distribution may allow for the 
differentiation of viable from non-viable myocardi- 
um by assessment of rubidium-82 tissue retention. 
Using dynamic data acquisition protocols with PET, 
the regional kinetics of rubidium-82 can be assessed. 
These data can then be compared to metabolic imaging 
with tracers such as FDG to help differentiate viable 
myocardium from irreversibly injured tissue in patients 
with recent myocardial infarction. Such techniques 
were not employed in the current study and require 
further validation in order to define the best imaging 
approach for rubidium-82 as a marker of tissue viabil- 
ity. 
Conclusions 
Both thallium-201 SPECT and rubidium-82 PET 
detect coronary artery disease with similar sensitivi- 
ties. The presence of rubidium-82 reflow and normal 
rubidium-82 uptake in sites of 'fixed' thallium-201 
SPECT perfusion defects suggests that imaging modal- 
ities employing separate stress and rest injection of 
tracer, such as rubidium-82 PET, may offer improved 
specificity in the assessment of myocardial viability, 
especially in patients with prior myocardial infarction. 
Metabolic imaging studies using tracers such as FDG 
are needed for the validation of these methods. 
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